þ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 37-1532842 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. | |
Suite | 33180 | |
(Zip Code) |
Large accelerated filer | o | Accelerated filer | o |
Non-accelerated filer | o | Smaller reporting company | þ |
(Do not check if a smaller company) |
Page | ||||||
PART | I. FINANCIAL INFORMATION | |||||
1 | ||||||
1 | ||||||
(Unaudited) | 2 | |||||
3 | ||||||
4 | ||||||
6 | ||||||
7 | ||||||
7 | ||||||
PART | II. OTHER INFORMATION | |||||
8 | ||||||
8 | ||||||
8 | ||||||
8 | ||||||
8 | ||||||
8 | ||||||
9 |
March 31, | December 31, | |||||||
2014 | 2013 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | - | $ | - | ||||
TOTAL CURRENT ASSETS / TOTAL ASSETS | $ | - | $ | - | ||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
LIABILITIES | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 1,459 | $ | 1,459 | ||||
Accrued liabilities | 21,299 | 21,281 | ||||||
Amount due to a related party | 64,592 | 54,493 | ||||||
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES | 87,350 | 77,233 | ||||||
STOCKHOLDERS’ DEFICIT | ||||||||
Preferred stock: par value of $0.001 per share Authorized: 10,000,000 shares at March 31, 2014 and December 31, 2013 Issued and outstanding: 0 shares at March 31, 2014 and December 31, 2013 | - | - | ||||||
Common stock: par value of $0.001 per share Authorized: 250,000,000 shares at March 31, 2014 and December 31, 2013 Issued and outstanding: 20,006,402 shares at March 31, 2014 and December 31, 2013 | 20,006 | 20,006 | ||||||
Additional paid-in-capital | 609,614 | 609,614 | ||||||
Retained earnings deficit | (716,970 | ) | (706,853 | ) | ||||
TOTAL STOCKOLDERS’ DEFICIT | (87,350 | ) | (77,233 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ | - | $ | - |
September 30, | December 31, | |||||||
2014 | 2013 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | - | $ | - | ||||
TOTAL CURRENT ASSETS / TOTAL ASSETS | $ | - | $ | - | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
LIABILITIES | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 2,078 | $ | 1,459 | ||||
Other payables and accrued liabilities | 5,000 | 21,281 | ||||||
Amount due to a related party | 94,130 | 54,493 | ||||||
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES | 101,208 | 77,233 | ||||||
STOCKHOLDERS’ EQUITY | ||||||||
Preferred stock : par value of $0.001 per share, | ||||||||
Authorized: 10,000,000 shares at September 30, 2014 and December 31, 2013 | ||||||||
Issued and outstanding : 0 shares at September 30, 2014 and December 31, 2013 | - | - | ||||||
Common stock : par value $0.001 per share | ||||||||
Authorized : 250,000,000 shares at September 30, 2014 and December 31, 2013 | ||||||||
Issued and outstanding : 20,006,402 shares at September 30, 2014 and December 31, 2013 | 20,006 | 20,006 | ||||||
Additional paid-in capital | 609,614 | 609,614 | ||||||
Retained earnings (deficit) | (730,828 | ) | (706,853 | ) | ||||
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) | (101,208 | ) | (77,233 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 0 | $ | 0 |
Three months ended March 31, | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | 2014 | 2013 | |||||||||||||||||||
Administrative expenses | $ | (10,117 | ) | $ | (4,559 | ) | (8,295 | ) | (11,449 | ) | (23,975 | ) | (22,597 | ) | ||||||||||
Other income | - | - | - | - | ||||||||||||||||||||
Loss before income taxes | (10,117 | ) | (4,559 | ) | (8,295 | ) | (11,449 | ) | (23,975 | ) | (22,597 | ) | ||||||||||||
Provision for income taxes | - | - | - | - | - | - | ||||||||||||||||||
Net loss | (10,117 | ) | (4,559 | ) | $ | (8,295 | ) | $ | (11,449 | ) | $ | (23,975 | ) | $ | (22,597 | ) | ||||||||
Earnings per share | ||||||||||||||||||||||||
-Basic and diluted | $ | 0.00 | $ | 0.00 | ||||||||||||||||||||
-Basic and Diluted | $ | * | $ | * | $ | * | $ | * | ||||||||||||||||
Weighted average number of shares outstanding | ||||||||||||||||||||||||
-Basic and diluted | 20,006,402 | 20,006,402 | ||||||||||||||||||||||
Weighted average number of shares outstanding: | ||||||||||||||||||||||||
- Basic and Diluted | 20,006,402 | 20,006,402 | 20,006,402 | 20,006,402 |
Period ended September 30, | ||||||||
2014 | 2013 | |||||||
Cash flows from operating activities | ||||||||
Net income (loss) | $ | (23,975 | ) | $ | (22,597 | ) | ||
Changes in operating assets and liabilities : | ||||||||
Accounts payable | 618 | 749 | ||||||
Other payables and accrued liabilities | (16,281 | ) | (7,500 | ) | ||||
Amount due to a related party | 39,638 | 29,348 | ||||||
Net cash flows used by operating activities | - | - | ||||||
Cash flows from investing activities | - | - | ||||||
Cash flows from financing activities | - | - | ||||||
Net decrease in cash and cash equivalents | - | - | ||||||
Cash and cash equivalents - beginning of period | - | - | ||||||
Cash and cash equivalents - end of period | $ | - | $ | - | ||||
Supplemental disclosures for cash flow information: | ||||||||
Cash paid for interest | $ | - | $ | - | ||||
Cash paid for income taxes | $ | - | $ | - |
Three months ended March 31, | ||||||||
2014 | 2013 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (10,117 | ) | $ | (4,559 | ) | ||
Changes in operating assets and liabilities: | ||||||||
Accounts payable | - | - | ||||||
Accrued liabilities | 18 | 4,559 | ||||||
Amount due to a related party | 10,099 | - | ||||||
Net cash flows used by operating activities | - | - | ||||||
Cash flows from investing activities | - | - | ||||||
Cash flows from financing activities | - | - | ||||||
Net decrease in cash and cash equivalents | - | - | ||||||
Cash and cash equivalents – beginning of period | - | - | ||||||
Cash and cash equivalents – end of period | $ | - | $ | - | ||||
Supplemental disclosures for cash flow information: | ||||||||
Cash paid for interest | $ | - | $ | - | ||||
Cash paid for income taxes | $ | - | $ | - |
Exhibit No. | Description | |
31 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 |
GREEN PLANET BIOENGINEERING CO., LTD. | |||
Date: | By: | ||
Jordan Weingarten | |||
President and Chief Financial Officer | |||
(Principal Executive Officer and | |||
Principal Financial Officer) |